Register entry

Labortoire Schmidt-Nagel Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
2
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 2.

Dosage formNDCs
powder2
RouteNDCs
Labeller name on the listingNDCs
labortoire schmidt-nagel inc.2
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
-Allium cepa, Ambrosia artemisiifolia, Arundo mauritanica, Dulcamara, Euphrasia officinalis, Nux vomica, Pulsatilla, Ranunculus bulbosus, Sabadilla, Sinapis nigra, Sticta pulmonaria, Wyethia helenoidespowder73296-071DRUG FOR FURTHER PROCESSING
-Cinchona officinalis, Cocculus indicus, Arnica montana, Coffea cruda, Tabacumpowder73296-021DRUG FOR FURTHER PROCESSING
Compare

Other companies listing allium cepa, ambrosia artemisiifolia, arundo mauritanica, dulcamara, euphrasia officinalis, nux vomica, pulsatilla, ranunculus bulbosus, sabadilla, sinapis nigra, sticta pulmonaria, wyethia helenoides

Enquiry

Common questions

Is Labortoire Schmidt-Nagel Inc. FDA approved?
Labortoire Schmidt-Nagel Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Labortoire Schmidt-Nagel Inc. make?
2 products are listed under Labortoire Schmidt-Nagel Inc. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.